SCHEMBL7125972

SCHEMBL7125972

Cn1cnc(S(=O)(=O)N(c2c(-c3ccc4c(c3)OCO4)c(OCCOc3ncc(Cl)cn3)nn2C)S(=O)(=O)c2cn(C)cn2)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.33
MALT1 Q9UDY8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PIK3CD O00329 1/20 0.32
KMT2A Q03164 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 2/20 0.32
HPGD P15428 2/20 0.32
ALOX15 P16050 2/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPT P10636 2/20 0.32
ALOX12 P18054 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
FYN P06241 1/20 0.30
MAPK1 P28482 1/20 0.30
DPP4 P27487 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6289667 0.87 PIK3CD (0.37) PTGS2MALT1PIK3CDKMT2AKDM4E
SCHEMBL6289257 0.87 ALDH1A1 (0.35) PTGS2MALT1PIK3CDKMT2AKDM4E
SCHEMBL6293273 0.85 FBP1 (0.36) PTGS2MALT1PIK3CDKMT2AKDM4E
SCHEMBL6293067 0.77 PIK3CD (0.45) PTGS2MALT1PIK3CDKMT2AKDM4E
SCHEMBL6293084 0.77 KMT2A (0.42) MALT1KMT2AKDM4EMEN1ALDH1A1
SCHEMBL6292720 0.75 PIK3CD (0.39) PTGS2MALT1PIK3CDKMT2AKDM4E
SCHEMBL6289882 0.74 HPGD (0.40) MALT1PIK3CDKMT2AKDM4EMEN1
SCHEMBL6289757 0.73 GAA (0.38) ALDH1A1GAATSHRMAPTSMN1; SMN2
SCHEMBL6293253 0.73 ADORA2A (0.41) PTGS2PIK3CDKMT2AMEN1HPGD
SCHEMBL7129748 0.72 PIK3CD (0.35) MALT1L3MBTL1PIK3CDKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232848-A1 Pyrazole compositions PFIZER INC. 2003-12-18 US disclosed
US-6573270-B1 Endothelin receptor antagonists PFIZER INC. 2003-06-03 US disclosed
EP-1072597-A1 Pyrazoles and their use as endothelin antagonists Pfizer Limited (GB) 2001-01-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232848-A1 Pyrazole compositions EDNRB, EDNRA, AGTR1 PTGS2 698/4885MALT1 2189/4885L3MBTL1 3883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.